In colorectal cancer, bacterial-driven inflammation and tumor development are reduced by the activation of the interleukin-1 receptor type 1 (IL-1R1) signaling pathway that takes place in neutrophils [150]. This evidence concerns the gene IL1R1 and colorectal cancer.